Fig. 1From: TTK is a potential therapeutic target for cisplatin-resistant ovarian cancerA The induction process of cisplatin-resistant ovarian cancer cell line A2780cis. B IC50 values of cisplatin in A2780 and A2780cis cells were analyzed by CCK-8 assay. The cisplatin concentrations used were as follows: 1 μg/mL, 2 μg/mL, 4 μg/mL, 8 μg/mL, 16 μg/mL, 32 μg/mL, 64 μg/mL, 128 μg/mLBack to article page